Products Bexarotene
Bexarotene Approved Completed 0 watching 0 views this week๐ฅ Hot Refractory Cutaneous T-cell Lymphoma
Refractory Cutaneous T-cell Lymphoma
Jan 6, 2010 โ Feb 20, 2014
About Bexarotene Bexarotene is a approved stage product being developed by Bausch Health for Refractory Cutaneous T-cell Lymphoma. The current trial status is completed. This product is registered under clinical trial identifier NCT01007448. Target conditions include Refractory Cutaneous T-cell Lymphoma.
Clinical Trials (1) NCT ID Phase Status Start Completion Indication NCT01007448 Approved Completed Jan 6, 2010 Feb 20, 2014 Refractory Cutaneous T-cell Lymphoma
Competing Products 20 competing products in Refractory Cutaneous T-cell Lymphoma
See all competitors Product Company Stage Hype Score Abemaciclib, dexamethasone, ixazomib, pomalidomide + Enasidenib, dexamethasone, ixazomib, pomalidomide + Cobimetinib, dexamethasone, ixazomib, pomalidomide + Erdafitinib, dexamethasone, ixazomib, pomalidomide + Venetoclax, dexamethasone, ixazomib, pomalidomide + Daratumumab, dexamethasone, ixazomib, pomalidomide + Belantamab mafodotin, dexamethasone, ixazomib, pomalidomide + Selinexor, dexamethasone, ixazomib, pomalidomide Eli Lilly Phase 1/2 agenT-797 MiNK Therapeutics Phase 1 eFT508 + Avelumab eFFECTOR Therapeutics Phase 2 CT-P44(Daratumumab) + Darzalex Faspro(Daratumumab) Celltrion Phase 3 Valemetostat Tosylate Daiichi Sankyo Phase 2 Enzalutamide Astellas Pharma Phase 2 ASP1650 Astellas Pharma Phase 2 YM598 Astellas Pharma Phase 2 erlotinib + etoposide Astellas Pharma Phase 2 Mitoxantrone Hydrochloride Liposome & Enlonstobart Sun Pharmaceutical Phase 1/2 Lenvatinib + Everolimus Eisai Phase 1/2 perampanel + perampanel + perampanel + Placebo Eisai Phase 3 Eribulin mesilate + Irinotecan hydrochloride Eisai Phase 1/2 perampanel Eisai Phase 2 rabeprazole sodium Eisai Pre-clinical Lenvatinib Eisai Phase 2 E2007 (perampanel) + E2007 (perampanel) + Placebo Eisai Phase 3 E2007 (perampanel) + E2007 (perampanel) + Placebo Eisai Phase 3 Tazemetostat Eisai Phase 2 Rufinamide Eisai Phase 3
Other Products from Bausch Health